Peter Gæde
Peter Gæde
Associate Professor of Medicine
Bekræftet mail på dadlnet.dk
Titel
Citeret af
Citeret af
År
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
P Gæde, P Vedel, N Larsen, GVH Jensen, HH Parving, O Pedersen
New England Journal of Medicine 348 (5), 383-393, 2003
55202003
Effect of a multifactorial intervention on mortality in type 2 diabetes
P Gæde, H Lund-Andersen, HH Parving, O Pedersen
New England Journal of Medicine 358 (6), 580-591, 2008
37772008
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study
P Gæde, P Vedel, HH Parving, O Pedersen
The Lancet 353 (9153), 617-622, 1999
11811999
Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus
J Ek, G Andersen, SA Urhammer, PH Gaede, T Drivsholm, ...
Diabetologia 44 (12), 2220-2226, 2001
3612001
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
P Gæde, J Oellgaard, B Carstensen, P Rossing, H Lund-Andersen, ...
Diabetologia 59 (11), 2298-2307, 2016
2962016
Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria
P Gæde, L Tarnow, P Vedel, HH Parving, O Pedersen
Nephrology Dialysis Transplantation 19 (11), 2784-2788, 2004
2342004
Double‐blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients
P Gaede, HE Poulsen, HH Parving, O Pedersen
Diabetic Medicine 18 (9), 756-760, 2001
1682001
Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study
P Gæde, WJ Valentine, AJ Palmer, DMD Tucker, M Lammert, HH Parving, ...
Diabetes Care 31 (8), 1510-1515, 2008
1612008
Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis
P Gæde, O Pedersen
Diabetes 53 (suppl 3), S39-S47, 2004
1412004
Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy
P Rossing, K Rossing, P Gæde, O Pedersen, HH Parving
Diabetes care 29 (5), 1024-1030, 2006
1272006
Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study
O Pedersen, P Gæde
Metabolism 52, 19-23, 2003
1082003
Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria
P Gaede, P Hildebrandt, G Hess, HH Parving, O Pedersen
Diabetologia 48 (1), 156-163, 2005
1062005
A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes
S Maeda, M Kobayashi, S Araki, T Babazono, BI Freedman, MA Bostrom, ...
PLoS Genet 6 (2), e1000842, 2010
972010
The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes
PH Gaede, PV Jepsen, JN Larsen, GV Jensen, HH Parving, OB Pedersen
Ugeskrift for laeger 165 (26), 2658-2661, 2003
652003
Polymorphisms in the 3′ UTR in the neurocalcin δ gene affect mRNA stability, and confer susceptibility to diabetic nephropathy
M Kamiyama, M Kobayashi, S Araki, A Iida, T Tsunoda, K Kawai, ...
Human genetics 122 (3-4), 397-407, 2007
622007
Limited impact of lifestyle education in patients with Type 2 diabetes mellitus and microalbuminuria: results from a randomized intervention study
P Gaede, M Beck, P Vedel, O Pedersen
Diabetic Medicine 18 (2), 104-108, 2001
552001
Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits
J Oellgaard, P Gæde, P Rossing, F Persson, HH Parving, O Pedersen
Kidney international 91 (4), 982-988, 2017
512017
Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised …
J Oellgaard, P Gæde, P Rossing, R Rørth, L Køber, HH Parving, ...
Diabetologia 61 (8), 1724-1733, 2018
362018
40th EASD Annual Meeting of the European Association for the Study of Diabetes: Munich, Germany, 5–9 September 2004
M Veitenhansl, K Stegner, FX Hierl, C Dieterle, H Feldmeier, B Gutt, ...
Diabetologia 47, A1-A464, 2004
312004
Impact of low‐dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion rate
P Gæde, HP Hansen, HH Parving, O Pedersen
Nephrology Dialysis Transplantation 18 (3), 539-542, 2003
302003
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20